Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A-Reference-Cited by-同舟云学术

Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A

Published:2020-08-25 Issue: Volume:11 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Visigalli Davide,Capodivento Giovanna,Basit Abdul,Fernández Roberto,Hamid Zeeshan,Pencová Barbora,Gemelli Chiara,Marubbi Daniela,Pastorino Cecilia,Luoma Adrienne M.,Riekel Christian,Kirschner Daniel A.,Schenone Angelo,Fernández José A.,Armirotti Andrea,Nobbio Lucilla

Funder

Fondazione Italiana Sclerosi Multipla

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference101 articles.

1. Demyelinating CMT–what's known, what's new and what's in store?;Brennan;Neurosci Lett.,2015

2. Charcot-Marie-Tooth diseases: an update and some new proposals for the classification;Mathis;J Med Genet.,2015

3. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication;Timmerman;Nat Genet.,1992

4. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A;Patel;Nat Genet.,1992

5. Inherited neuropathies;Schenone;Curr Treat Options Neurol.,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles for PMP22 in Schwann cell cholesterol homeostasis in health and disease;Biochemical Society Transactions;2024-07-09

2. PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cells;Brain;2024-05-14

3. Tezacaftor is a direct inhibitor of sphingolipid delta-4 desaturase enzyme (DEGS);Journal of Cystic Fibrosis;2024-05

4. Monitoring myelin lipid composition and structure of myelinated fibers reveals a maturation delay in CMT1A;2024-03-08

5. Charcot-Marie-Tooth disease: from historical landmarks in Brazil to current care perspectives;Arquivos de Neuro-Psiquiatria;2023-08-23